This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Flamel Technologies' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Stocks in this article: FLML

Flamel Technologies S.A. (FLML)

Q2 2012 Earnings Conference Call

July 26, 2012 08:30 ET

Executives

Mike Anderson – Chief Executive Officer

Sian Crouzet – Principal Financial Officer

Analysts

Matt Kaplan – Ladenburg Thalmann

David Moskowitz – Private Investor

Peter Butler – Glen Hill Investments

Presentation

Operator

Good morning, ladies and gentlemen and welcome to the Flamel Technologies’ Second Quarter 2012 Results Conference Call. After prepared remarks, we’ll be opening the call to a Q&A period. (Operator Instructions) As a reminder, this call is being recorded.

It is now my pleasure to turn the call over to Mike Anderson, CEO. Please go ahead sir.

Mike Anderson

Thank you, operator, and good morning, ladies and gentlemen. We appreciate very much your joining us today.

Before we begin, I’ll have to open with our usual forward-looking statement language, which is also included in last night’s press release. All statements made on this call about future events, results, performance, products under development, plans or objectives are forward-looking. Actual results may differ materially from these statements due to risks and uncertainties over which we have no control. We encourage our shareholders to review the risk and other disclosures set forth in our SEC filings, which are all publicly available.

It remains a period of transition and transformation for Flamel and I am happy to report that we continue to gain momentum during the past quarter, becoming a more vertically integrated pharmaceutical company, and therefore a company better able to control its own future, remains a key priority for us and we continue to believe it is our best opportunity for delivering sustainable growth and shareholder value. Partnering our world-class drug delivery platforms continues to be a key part of our strategy that our expanded commercialization capabilities are now allowing Flamel to offer even more value to shareholders as our internal projects advance towards commercialization.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs